BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Neganova M, Liu J, Aleksandrova Y, Klochkov S, Fan R. Therapeutic Influence on Important Targets Associated with Chronic Inflammation and Oxidative Stress in Cancer Treatment. Cancers (Basel) 2021;13:6062. [PMID: 34885171 DOI: 10.3390/cancers13236062] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Tang Y, Chen K, Xiao Z, Hong G, Hu L, Cai J, Lu Z. A novel mechanism of Dimethyl ester of Alpha-ketoglutarate in suppressing Paraquat-induced BEAS-2B cell injury by alleviating GSDME dependent pyroptosis. Phytomedicine 2023;112:154698. [PMID: 36773430 DOI: 10.1016/j.phymed.2023.154698] [Reference Citation Analysis]
2 Ren Z, Zhang J, Zheng D, Luo Y, Song Z, Chen F, Li A, Liu X. Identification of Prognosis-Related Oxidative Stress Model with Immunosuppression in HCC. Biomedicines 2023;11:695. [DOI: 10.3390/biomedicines11030695] [Reference Citation Analysis]
3 Janicic A, Petrovic M, Zekovic M, Vasilic N, Coric V, Milojevic B, Zivkovic M, Bumbasirevic U. Prognostic Significance of Systemic Inflammation Markers in Testicular and Penile Cancer: A Narrative Review of Current Literature. Life 2023;13:600. [DOI: 10.3390/life13030600] [Reference Citation Analysis]
4 Zamborlin A, Voliani V. Gold nanoparticles as antiangiogenic and antimetastatic agents. Drug Discov Today 2023;28:103438. [PMID: 36375738 DOI: 10.1016/j.drudis.2022.103438] [Reference Citation Analysis]
5 Zhang X, Ma Y, Lv G, Wang H. Ferroptosis as a therapeutic target for inflammation-related intestinal diseases. Front Pharmacol 2023;14:1095366. [PMID: 36713828 DOI: 10.3389/fphar.2023.1095366] [Reference Citation Analysis]
6 Catalano M, Roviello G, Santi R, Villari D, Spatafora P, Galli IC, Sessa F, Conte FL, Mini E, Cai T, Nesi G. Inflammation in Urological Malignancies: The Silent Killer. Int J Mol Sci 2023;24. [PMID: 36614308 DOI: 10.3390/ijms24010866] [Reference Citation Analysis]
7 Tuli HS, Kaur J, Vashishth K, Sak K, Sharma U, Choudhary R, Behl T, Singh T, Sharma S, Saini AK, Dhama K, Varol M, Sethi G. Molecular mechanisms behind ROS regulation in cancer: A balancing act between augmented tumorigenesis and cell apoptosis. Arch Toxicol 2023;97:103-20. [PMID: 36443493 DOI: 10.1007/s00204-022-03421-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Roa JC, García P, Kapoor VK, Maithel SK, Javle M, Koshiol J. Gallbladder cancer. Nat Rev Dis Primers 2022;8:69. [PMID: 36302789 DOI: 10.1038/s41572-022-00398-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Jiang R, Cao M, Mei S, Guo S, Zhang W, Ji N, Zhao Z. Trends in metabolic signaling pathways of tumor drug resistance: A scientometric analysis. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.981406] [Reference Citation Analysis]
10 Ranasinghe R, Mathai M, Zulli A. Revisiting the therapeutic potential of tocotrienol. Biofactors 2022. [PMID: 35719120 DOI: 10.1002/biof.1873] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Sumiyoshi A, Shibata S, Zhelev Z, Miller T, Lazarova D, Aoki I, Obata T, Higashi T, Bakalova R. Targeting Glioblastoma via Selective Alteration of Mitochondrial Redox State. Cancers 2022;14:485. [DOI: 10.3390/cancers14030485] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]